When compared with the AKT/NICD model that we have previously established,22 the AKT/Jag1 mouse is more suitable for experimental therapeutics as it can be used to evaluate the potential of Notch inhibitors for the treatment of ICC. Here, JAG1 is linked to intrahepatic cholangiocarcinoma.